C. Erem, M. Kocak, I. Nuhoglu, et al., “Increased Plasminogen Activator Inhibitor-1, Decreased Tissue Factor Pathway Inhibitor, and Unchanged Thrombin-Activatable Fibrinolysis Inhibitor Levels in Patients with Primary Hyperparathyroidism,” European Journal of Endocrinology, Vol. 160, No. 5, 2009, pp. 863-868.
http://dx.doi.org/10.1530/EJE-09-0069

has been cited by the following article:

• TITLE: Thromboelastographic Profile of Patients with Hyperparathyroidism Secondary to Chronic Kidney Failure Submitted to Total Parathyroidectomy

  AUTHORS: Walkíria Wingester Vilas Boas, Cristiano Barbosa de Oliveira, Thadeu Alves Máximo, Carlos Alexandre de Freitas Trindade, Alexandre de Andrade Sousa

  KEYWORDS: Thromboelastography; Chronic Renal Failure; Hyperparathyroidism; Total Thyroidectomy

  JOURNAL NAME: Open Journal of Anesthesiology, Vol.3 No.8, October 28, 2013

  ABSTRACT: Coagulopathy in surgical patients can cause perioperative complications, as both bleeding and thromboembolic events increase surgical morbimortality. The recognition of preexisting disorders and the understanding of the dynamic changes in hemostasis during surgery are prerequisites of safe patient management. The perioperative management of patients with chronic kidney failure is a huge challenge due to both the hypercoagulable state and increased risk of bleeding. Classic laboratory exams performed for the evaluation of blood clotting seem insufficient regarding the determination of the risk of bleeding and thrombosis in surgical patients. As patients with chronic kidney failure develop secondary hyperparathyroidism, the aim of the present study was to describe a case series and correlate the perioperative thromboelastographic profile of patients with chronic kidney failure submitted to parathyroidectomy with their secondary hyperparathyroidism.